About Us
Dendrimer Technology
VIRALEZE™
VivaGel®
DEP® Drug Delivery
News
Search
Investor Centre
ASX Announcements
News Archive
2021 Annual General Meeting
Update Shareholder Information
Financial Reports
Analyst Coverage
Shareholder Newsletters
Corporate Governance
Email Alerts
Share Price History
Contact Us
Starpharma
Home
Investor Centre
ASX Announcements
ASX Announcements
Jan 2022
Jan 20th, 2022
Starpharma receives $7.7M R&D tax incentive refund
2022
2021
2020
2019
2018
2017
2016
